Resultados de procura - Matthew D. Linden

  • Mostrando 1 - 11 Resultados de 11
Limitar resultados
  1. 1
    Acute changes to biomarkers as a consequence of prolonged strenuous running

    Acute changes to biomarkers as a consequence of prolonged strenuous running por Stephen R. Bird, Matthew D. Linden, John A. Hawley

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization

    Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization por Mark I. Furman, Lori A. Krueger, Matthew D. Linden, Marc R. Barnard, Andrew L. Frelinger, Alan D. Michelson

    Publicado 2004
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Aspirin ‘resistance’: role of pre‐existent platelet reactivity and correlation between tests

    Aspirin ‘resistance’: role of pre‐existent platelet reactivity and correlation between tests por Andrew L. Frelinger, Y. LI, Matthew D. Linden, Inge Tarnow, M.R. BARNARD, Marsha L. Fox, Alan D. Michelson

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway

    Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway por Andrew L. Frelinger, Mark I. Furman, Matthew D. Linden, Youfu Li, Marsha L. Fox, Marc R. Barnard, Alan D. Michelson

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity

    Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity por M.R. BARNARD, Matthew D. Linden, Andrew L. Frelinger, Y. LI, Marsha L. Fox, M.I. Furman, Alan D. Michelson

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Indices of platelet activation and the stability of coronary artery disease

    Indices of platelet activation and the stability of coronary artery disease por Matthew D. Linden, M.I. Furman, Andrew L. Frelinger, Marsha L. Fox, M.R. BARNARD, Y. LI, Karin Przyklenk, Alan D. Michelson

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis

    Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis por Karin Przyklenk, Andrew L. Frelinger, Matthew D. Linden, Peter Whittaker, Y. LI, M.R. BARNARD, John Adams, Michael Morgan, Hussien Al‐Shamma, Alan D. Michelson

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia

    Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia por Bethan Psaila, James B. Bussel, Andrew L. Frelinger, Bracken Babula, Matthew D. Linden, Y. LI, M.R. BARNARD, Christian Tate, Eric J. Feldman, Alan D. Michelson

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation

    In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation por Bethan Psaila, James B. Bussel, Matthew D. Linden, Bracken Babula, Youfu Li, Marc R. Barnard, Chinara M. Tate, Kanika Mathur, Andrew L. Frelinger, Alan D. Michelson

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Platelet activation in cystic fibrosis

    Platelet activation in cystic fibrosis por Brian O’Sullivan, Matthew D. Linden, Andrew L. Frelinger, Marc R. Barnard, Michele Spencer‐Manzon, James E. Morris, Raneem O. Salem, Michael Laposata, Alan D. Michelson

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’

    Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’ por Alan D. Michelson, Matthew D. Linden, M.I. Furman, Yun Li, M.R. BARNARD, Marsha L. Fox, Wei C. Lau, Thomas J. McLaughlin, Andrew L. Frelinger

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: